ERBB2 and colorectal carcinoma: These data indicate that the enhancers are poised in both cellular fractions but only fully activated in the CD44v6-positive compartment, suggesting that the activation of Erbb2 transcription mediated by the increased acetylation is restricted to the CD44v6-positive CRC cell compartment.